International Journal of Cancer · 1989 · 17 citations · 19 references
MedicineCell BiologyOncologyMolecular OncologyMonoclonal AntibodiesOral OncologyImmunohistochemistryOral Cavity CancerSquamous Cell CarcinomaTumor AntigensTumor-associated AntigensAdenocarcinoma Of The CervixCancer AntigensCervical LeukoplakiaMonoclonal Antibodies In CancerMonoclonal Antibodies In OncologyOral Cavity PathologyScatchard AnalysisWestern Blotting
Mouse monoclonal antibody (MAb) 3F8E3 (IgG3k) was developed against the head and neck cancer cell line LICR-LON-HN2. Subjected to indirect immunofluorescence, the MAb reacted exclusively with SCC cell lines and showed no reactivity with normal or transformed mouse and human non-SCC cell lines and hematopoietic cell lines. The radiolabelled MAb showed an affinity constant of 1.8 x 10(8) M-1 with HN2 cells and identified 2.07 x 10(4) sites/cell by Scatchard analysis. It identified 2 peptides from membrane extracts of HN2 cells by Western blotting. Avidin-biotin-complexed immunoperoxidase staining on cryostat sections of tumors from various tissues revealed that 3F8E3 reacted mainly with the membrane antigens of well differentiated SCC cells of oral cavity, larynx, esophagus, lung, uterine cervix, metastatic nodes of patients with oral cancer, and dysplastic cells in oral leukoplakia. The MAb did not react with poorly differentiated cells of Ca esophagus, adenocarcinoma of breast, stomach and colon, renal-cell carcinoma and soft-tissue sarcoma.
19
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck
D M Easty, G C Easty, R L Carter et al. · British Journal of Cancer · 1981 · 182 citations
Medicine, Cell Biology, Oncology +9
Antibodies to human squamous cell carcinoma
Thomas E. Carey, Kathryn A. Kimmel, D. R. Schwartz et al. · Otolaryngology · 1983 · 75 citations
Medicine, Immunology, Oncology +17